DE69929986D1 - Verfahren zur entfernung von hiv und anderen viren aus blut - Google Patents

Verfahren zur entfernung von hiv und anderen viren aus blut

Info

Publication number
DE69929986D1
DE69929986D1 DE69929986T DE69929986T DE69929986D1 DE 69929986 D1 DE69929986 D1 DE 69929986D1 DE 69929986 T DE69929986 T DE 69929986T DE 69929986 T DE69929986 T DE 69929986T DE 69929986 D1 DE69929986 D1 DE 69929986D1
Authority
DE
Germany
Prior art keywords
blood
viruses
viral
reducing
components
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69929986T
Other languages
English (en)
Other versions
DE69929986T2 (de
Inventor
Julian L Ambrus
David O Scamurra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE69929986D1 publication Critical patent/DE69929986D1/de
Application granted granted Critical
Publication of DE69929986T2 publication Critical patent/DE69929986T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/20—Pathogenic agents
    • A61M2202/206—Viruses
DE69929986T 1998-08-31 1999-08-30 Verfahren zur entfernung von hiv und anderen viren aus blut Expired - Lifetime DE69929986T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9847798P 1998-08-31 1998-08-31
US98477P 1998-08-31
PCT/US1999/019448 WO2000012103A1 (en) 1998-08-31 1999-08-30 Method for removal of hiv and other viruses from blood

Publications (2)

Publication Number Publication Date
DE69929986D1 true DE69929986D1 (de) 2006-04-27
DE69929986T2 DE69929986T2 (de) 2006-10-19

Family

ID=22269457

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69929986T Expired - Lifetime DE69929986T2 (de) 1998-08-31 1999-08-30 Verfahren zur entfernung von hiv und anderen viren aus blut

Country Status (7)

Country Link
US (1) US6528057B1 (de)
EP (1) EP1109564B1 (de)
AT (1) ATE318176T1 (de)
AU (1) AU770344B2 (de)
CA (1) CA2342203C (de)
DE (1) DE69929986T2 (de)
WO (1) WO2000012103A1 (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8197430B1 (en) * 1998-05-22 2012-06-12 Biopheresis Technologies, Inc. Method and system to remove cytokine inhibitor in patients
US6620382B1 (en) * 1998-05-22 2003-09-16 Biopheresis Technologies, Llc. Method and compositions for treatment of cancers
US6379708B1 (en) * 1999-11-20 2002-04-30 Cytologic, Llc Method for enhancing immune responses in mammals
US8491884B2 (en) 2000-05-03 2013-07-23 Oncolytics Biotech Inc. Virus clearance of neoplastic cells from mixed cellular compositions
AR028040A1 (es) * 2000-05-03 2003-04-23 Oncolytics Biotech Inc Remocion de virus de celulas neoplasticas a partir de composiciones celulares mixtas
AR028039A1 (es) 2000-05-03 2003-04-23 Oncolytics Biotech Inc Remocion de reovirus de celulas neoplasticas intermediadas por ras a partir de composiciones celulares mixtas
US7306902B2 (en) * 2002-06-28 2007-12-11 Oncolyties Biotech Inc. Oncolytic viruses as phenotyping agents for neoplasms
US8865172B2 (en) * 2000-05-08 2014-10-21 Advanced Extravascular Systems, Inc. Method for reducing the number of unwanted molecules in bodily fluids
US7465540B2 (en) * 2000-09-21 2008-12-16 Luminex Corporation Multiple reporter read-out for bioassays
AU2003290506A1 (en) * 2002-04-02 2004-04-30 Scantibodies Laboratory, Inc. Methods and devices for treating severe peripheral bacterial infections
EP1624785B1 (de) * 2003-01-17 2013-07-17 Aethlon Medical, Inc. Verfahren zur entfernung von viren aus dem blut durch lektin-affinitäts-hämodialyse
US20040259076A1 (en) * 2003-06-23 2004-12-23 Accella Scientific, Inc. Nano and micro-technology virus detection method and device
EP1737428B1 (de) * 2004-03-31 2017-08-30 University of Utah Research Foundation Makromolekulare abgabesysteme für die nichtinvasive darstellung, untersuchung und behandlung von arthritis und anderen entzündlichen erkrankungen
SI1949915T1 (sl) * 2004-04-30 2012-12-31 Biopheresis Technologies, Inc. Postopek in sistem za odstranitev topnih TNFR1, TNFR2 in IL2R pri pacientih
EP1799840A4 (de) 2004-09-03 2009-02-18 Univ Columbia Ilt3-polypeptide und verwendungen davon
US20070065514A1 (en) * 2005-09-22 2007-03-22 Howell Mark D Method for enhancing immune responses in mammals
WO2007089945A2 (en) * 2006-02-02 2007-08-09 The Trustees Of Columbia University In The City Of New York Treating diseases by targeting silt3
DK3517151T3 (da) 2006-03-09 2021-07-12 Aethlon Medical Inc Ekstrakorporal fjernelse af mikrovesikulære partikler
US8057418B2 (en) * 2007-03-01 2011-11-15 Nanospectra Biosciences, Inc. Devices and methods for extracorporeal ablation of circulating cells
WO2009023332A2 (en) * 2007-05-16 2009-02-19 Aethlon Medical, Inc. Device and method for purifying virally infected blood
EP2238079A4 (de) * 2007-12-27 2014-07-02 Aethlon Medical Inc Verfahren und vorrichtung zur erhöhung der fremdstoff-clearance-raten bei der extrakorporalen fluidbehandlung
WO2009149179A2 (en) * 2008-06-03 2009-12-10 Aethlon Medical Inc. Enhanced antiviral therapy methods and devices
AU2014259591B2 (en) * 2008-06-13 2016-03-03 Elster Solutions, Llc Techniques for limiting demand from an electricity meter with an installed relay
WO2010014702A1 (en) * 2008-07-29 2010-02-04 Medtronic, Inc. Apheresis of a target molecule from cerebrospinal fluid
WO2010065765A2 (en) * 2008-12-04 2010-06-10 Aethlon Medical, Inc. Affinity capture of circulating biomarkers
US20110033463A1 (en) * 2009-08-06 2011-02-10 Medtronic, Inc. Apheresis, administration of agent, or combination thereof
WO2011046504A1 (en) * 2009-10-18 2011-04-21 Glycorex Ab Method and product for blood treatment and purification
AU2010324594B2 (en) 2009-11-30 2016-09-15 Caris Life Sciences Switzerland Holdings Gmbh Methods and systems for isolating, storing, and analyzing vesicles
US9694128B1 (en) * 2010-02-24 2017-07-04 Brian LeBerthon Device and method for administering an anti-cancer substance
EP2542696B1 (de) 2010-03-01 2016-09-28 Caris Life Sciences Switzerland Holdings GmbH Theranostik-biomarker
AU2011237669B2 (en) 2010-04-06 2016-09-08 Caris Life Sciences Switzerland Holdings Gmbh Circulating biomarkers for disease
US9696312B2 (en) 2011-09-02 2017-07-04 The Trustees Of Columbia University In The City Of New York Diagnosis and treatment of cancer expressing ILT3 or ILT3 ligand
US9227005B2 (en) 2013-03-14 2016-01-05 Brian J LeBerthon Method and device for treating cancer
US20170035955A1 (en) * 2015-03-27 2017-02-09 Eliaz Therapeutics, Inc. Apheresis based treatment for kidney disease
WO2017015227A1 (en) 2015-07-17 2017-01-26 The Trustees Of Columbia University In The City Of New York Methods of treating cd166-expressing cancer
CN106267416B (zh) * 2016-07-01 2019-02-19 翁炳焕 艾滋病治疗仪
CN106267414B (zh) * 2016-07-01 2019-02-19 翁炳焕 艾滋病免疫净化器
US10786614B2 (en) * 2016-10-24 2020-09-29 Henley Development Corporation Antigenic decoy entrapment filtration device and treatment methods for autoimmune disorders
CN117138146A (zh) 2017-09-18 2023-12-01 圣特萨斯股份公司 用于针对循环无细胞dna纯化血液的方法和装置
CN108653847A (zh) * 2018-02-11 2018-10-16 武汉瑞法医疗器械有限公司 一体式血浆分离艾滋病病毒免疫吸附器
CN108653846A (zh) * 2018-02-11 2018-10-16 武汉瑞法医疗器械有限公司 一体式血浆分离蛋白a免疫吸附器
CN108653848A (zh) * 2018-02-11 2018-10-16 武汉瑞法医疗器械有限公司 一体式血浆分离IgE免疫吸附器
CN108283738A (zh) * 2018-02-11 2018-07-17 武汉瑞法医疗器械有限公司 一体式血浆分离dna免疫吸附器
DE202018102428U1 (de) 2018-05-02 2019-02-28 Aleksandr A. Buslaev Elektrochemisches Einwirksystem auf den HIV-Virus im menschlichen Körper mittels Kathodenstrom
WO2023126672A1 (en) 2021-12-27 2023-07-06 Santersus Ag Method and device for removal of circulating cell free dna

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4787974A (en) * 1981-06-29 1988-11-29 Ambrus Clara M Blood purification
US4612122A (en) 1981-06-29 1986-09-16 Clara Ambrus Removing heavy metal ions from blood
US4668399A (en) * 1982-02-16 1987-05-26 E. I. Du Pont De Nemours And Company Hollow fiber plasmapheresis process
US5041079A (en) * 1987-12-04 1991-08-20 Kuraray Co., Ltd. Method for removing human immunodeficiency virus and/or its related compounds
US5123901A (en) * 1988-02-25 1992-06-23 Carew E Bayne Method for separating pathogenic or toxic agents from a body fluid and return to body
WO1993004732A1 (en) * 1991-09-09 1993-03-18 The Government Of The United States Of America, As Represented By The Secretary Department Of Health And Human Services Methods and devices for treating hemophilia and aids
JP3615785B2 (ja) * 1994-04-28 2005-02-02 テルモ株式会社 Ｈｉｖ及びその関連物質除去材料
AT403477B (de) * 1996-04-30 1998-02-25 Immuno Ag Biologisches material frei von viralen und molekularen pathogenen und verfahren zur herstellung
US5868936A (en) * 1996-06-20 1999-02-09 Baxter International Inc. Affinity membrane system and method of using same

Also Published As

Publication number Publication date
EP1109564A4 (de) 2003-05-02
EP1109564B1 (de) 2006-02-22
EP1109564A1 (de) 2001-06-27
AU770344B2 (en) 2004-02-19
CA2342203A1 (en) 2000-03-09
ATE318176T1 (de) 2006-03-15
US6528057B1 (en) 2003-03-04
AU5785299A (en) 2000-03-21
CA2342203C (en) 2011-03-01
WO2000012103A1 (en) 2000-03-09
DE69929986T2 (de) 2006-10-19

Similar Documents

Publication Publication Date Title
DE69929986D1 (de) Verfahren zur entfernung von hiv und anderen viren aus blut
DE60025529D1 (de) Magnetische glasteilchen, herstellungsverfahren und benutzung
DE60137203D1 (de) Poröse ferro- oder ferrimagnetische glasteilchen für molekültrennung
DE60027863D1 (de) Apherese von leukozyten aus blut zur behandlung von hiv
DE602006019111D1 (de) Verfahren zur isolierung von analyten aus einer probe
DE59010793D1 (de) Verfahren zur inaktivierung von viren in blut und blutprodukten
ATE186900T1 (de) Verfahren zur aeroben, weitergehenden biologischen reinigung von abwässern
DE69722491D1 (de) Adsorbens und Verfahren zur Entfernung von Chemokinen des CC-Subtyps aus Körperflüssigkeiten
DE60209095D1 (de) Verfahren zur Rückgewinnung von Katalysatormetallen
DE69807962T2 (de) Verfahren zur Reinigung von rohem 1,1,1,3,3-Pentafluorpropan
ATE515578T1 (de) Verfahren und vorrichtung zur nukleinsäurereinigung
ATE449104T1 (de) Verfahren zur reinigung von fibrinogen
DE69325948D1 (de) Entfernung von Antikörpern aus von Blut stammenden Zusammensetzungen unter Erhalt von Gerinnungsfaktoren
DE60021098D1 (de) Von isoagglutinin befreite blutzusammensetzungen und verfahren zu ihrer herstellung
ATE278785T1 (de) Neues verfahren zur gewinnung und reinigung von fusionsproteinen
ATE314391T1 (de) Methode zur reinigung von thrombopoietin
ATE401424T1 (de) Verfahren zur identifizierung von nukleinsäureliganden für gewebsziele
DE69502313T2 (de) Verfahren zur biologischen Reinigung von Gasströmen
ATE240140T1 (de) Methode und poröser träger zur entfernung von verunreinigungen
ATE434036T1 (de) Filtrationsverfahren zur trennung von viren
KR960031474A (ko) 한외여과에 의한 단백질 용액으로부터의 바이러스의 제거방법
ATE171884T1 (de) Verfahren zur umwandlung von komplexen chemischen strukturen unter reduzierenden bedingungen in einem superkritischen fluid
DE69924390D1 (de) Kohlenstoffaserfilter
DE60121815D1 (de) System und prozess zur reinigung und/oder behandlung von fahrzeugoberflächen
EP1679117A3 (de) Adsorptionssystem zur Entfernung von Viren und viralen Bestandteilen aus Flüssigkeiten, insbesondere aus Blut und Blutplasma

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: GRAF VON STOSCH PATENTANWALTSGESELLSCHAFT MBH, 805